Version Révisée SEPTEMBRE 2016
A field guide for accelerating and sustaining open defecation free communities through a Community-Led Total Sanitation approach
Follow-up MANDONA (FUM) is an action-oriented approach for accelerating community-wide sanitation and hygiene behaviour change following the initial triggering session. D...irectly based on Community-Led Total Sanitation (CLTS) principles, FUM involves a series of participatory, facilitated sessions that brings the entire community together to analyze their sanitation situation
and collectively undertake small, immediate and doable actions to end open defecation (OD) in the shortest time possible
more
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo...cus is maternal, neonatal and child health (MNCH), HIV and AIDS, malaria, and nutrition.
more
2015-16 Demographic and Health Survey and Malaria Indicator Survey
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...m interviewed more than120 individuals from approximately 78 organizations, including the government of Senegal (GOS), donors, USAID implementing partners, private sector umbrella organizations, private insurance companies, faith-based organizations (FBOs), nongovernmental organizations (NGOs), private health care facilities, and private pharmacies.
Through stakeholder interviews and review of government reports and online resources, the assessment team noted the following findings by theme.
more
Cette évaluation est axée en premier lieu sur la planification familiale et en second lieu sur la santé maternelle, néonatale et de l’enfant (SMNE), le VIH/sida, le paludisme et la nutrition. L’évaluation avait les objectifs suivants :
1. Produire un aperçu des parties prenantes du secte...ur privé de la santé et de leurs rôles respectifs
2. Évaluer le niveau du dialogue politique entre les secteurs public et privé de la santé 3. Décrire les contributions du secteur privé aux principaux marchés et domaines de la santé, y compris le financement de la santé
4. Évaluer les marchés spécifiques pour les principaux produits et services de santé, et décrire la dynamique de l’offre et de la demande
5. Identifier les opportunités actuelles et potentielles pour des partenariats public-privé dans le secteur de la santé
6. Fournir des recommandations sur les meilleures façons de rendre les partenariats public-privé (PPP) opérationnels dans le secteur de la santé
more
Further Analysis of the 2000, 2005, 2010, and 2014 Cambodia Demographic and Health Surveys | DHS Further Analysis Reports No. 106
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...ons
(FAO) passed a resolution on AMR at its governing
Conference. This followed the adoption of counterpart
resolutions on AMR by The World Organisation
for Animal Health (OIE) and the World Health Organization
(WHO) in May 20152, and marked the
beginning of a joint effort by the three organizations
to combat AMR globally.
more
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...ing access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
more
DHS Comparative Reports No. 41